Literature DB >> 15754731

Sodium iodide symporter expression and radioiodine distribution in extrathyroidal tissues.

R Bruno1, P Giannasio, G Ronga, E Baudin, J P Travagli, D Russo, S Filetti, M Schlumberger.   

Abstract

The functional role of the sodium iodide symporter (NIS) in extrathyroidal tissues was investigated by examining its mRNA and protein expression, together with the evidence of radioiodine (131)I uptake in 302 patients who underwent (131)I total body scanning, following the administration of high doses of (131)I for a papillary or follicular thyroid carcinoma. By using a real-time kinetic quantitative RT-PCR and immunohistochemistry, the expression of NIS protein was detected mainly in secretory tissues. In parallel, 1311 uptake was evidenced in the majority of patients in the salivary glands (in 39%) and stomach (in 78%), but was found in breast in only 4 young female patients. These data demonstrate a strong correlation between the organ radioactivity distribution, as observed in vivo, and NIS protein expression. Interestingly, (131)I is rarely concentrated by mammary glands, even when large doses are administered. Moreover, a (131)I transfer in secretion fluids may represent a potential source of contamination responsible for false positive images and diagnostic pitfalls.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15754731     DOI: 10.1007/BF03345302

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  24 in total

1.  Analysis of human sodium iodide symporter immunoreactivity in human exocrine glands.

Authors:  C Spitzweg; W Joba; K Schriever; J R Goellner; J C Morris; A E Heufelder
Journal:  J Clin Endocrinol Metab       Date:  1999-11       Impact factor: 5.958

2.  Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa.

Authors:  C Spitzweg; W Joba; W Eisenmenger; A E Heufelder
Journal:  J Clin Endocrinol Metab       Date:  1998-05       Impact factor: 5.958

Review 3.  Papillary and follicular thyroid carcinoma.

Authors:  M J Schlumberger
Journal:  N Engl J Med       Date:  1998-01-29       Impact factor: 91.245

4.  Na(+)/I(-) symporter and Pendred syndrome gene and protein expressions in human extra-thyroidal tissues.

Authors:  L Lacroix; C Mian; B Caillou; M Talbot; S Filetti; M Schlumberger; J M Bidart
Journal:  Eur J Endocrinol       Date:  2001-03       Impact factor: 6.664

5.  How frequently is the thymus seen on whole-body iodine-131 diagnostic and post-treatment scans?

Authors:  J Davidson; I R McDougall
Journal:  Eur J Nucl Med       Date:  2000-04

6.  Expression of thyroid-related genes in human thymus.

Authors:  C Spitzweg; W Joba; A E Heufelder
Journal:  Thyroid       Date:  1999-02       Impact factor: 6.568

7.  Iodine concentration by the thymus in thyroid carcinoma.

Authors:  F Vermiglio; E Baudin; J P Travagli; B Caillou; P Fragu; M Ricard; M Schlumberger
Journal:  J Nucl Med       Date:  1996-11       Impact factor: 10.057

8.  Side effects of "rational dose" iodine-131 therapy for metastatic well-differentiated thyroid carcinoma.

Authors:  D Van Nostrand; J Neutze; F Atkins
Journal:  J Nucl Med       Date:  1986-10       Impact factor: 10.057

9.  Relationship between thyrotropin stimulation and radioiodine uptake in lung metastases of differentiated thyroid carcinoma.

Authors:  M Schlumberger; P Charbord; P Fragu; P Gardet; J Lumbroso; C Parmentier; M Tubiana
Journal:  J Clin Endocrinol Metab       Date:  1983-07       Impact factor: 5.958

10.  Na+/I- symporter distribution in human thyroid tissues: an immunohistochemical study.

Authors:  B Caillou; F Troalen; E Baudin; M Talbot; S Filetti; M Schlumberger; J M Bidart
Journal:  J Clin Endocrinol Metab       Date:  1998-11       Impact factor: 5.958

View more
  16 in total

1.  Abnormal pelvic uptake on post-therapeutic radioiodine (131I) whole-body scan.

Authors:  Desiree Deandreis; Jean Lumbroso; Abir Al Ghuzlan; Eric Baudin; Martin Schlumberger; Sophie Leboulleux
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-04-02       Impact factor: 9.236

2.  THE OCCURRENCE OF ACUTE PANCREATITIS AFTER IODINE 131 TREATMENT OF HYPERTHYROIDISM.

Authors:  Y Liu; X Lou
Journal:  Acta Endocrinol (Buchar)       Date:  2022 Apr-Jun       Impact factor: 1.104

3.  The Na+/I- symporter mediates active iodide uptake in the intestine.

Authors:  Juan Pablo Nicola; Cécile Basquin; Carla Portulano; Andrea Reyna-Neyra; Monika Paroder; Nancy Carrasco
Journal:  Am J Physiol Cell Physiol       Date:  2008-12-03       Impact factor: 4.249

4.  Modulation of sodium/iodide symporter expression in the salivary gland.

Authors:  Krista M D La Perle; Dong Chul Kim; Nathan C Hall; Adam Bobbey; Daniel H Shen; Rebecca S Nagy; Paul E Wakely; Amy Lehman; David Jarjoura; Sissy M Jhiang
Journal:  Thyroid       Date:  2013-07-17       Impact factor: 6.568

5.  Regulation of sodium/iodide symporter and lactoperoxidase expression in four human breast cancer cell lines.

Authors:  M Sponziello; A Scipioni; C Durante; A Verrienti; M Maranghi; L Giacomelli; E Ferretti; M Celano; S Filetti; D Russo
Journal:  J Endocrinol Invest       Date:  2009-09-30       Impact factor: 4.256

6.  mRNA-Seq reveals novel molecular mechanisms and a robust fingerprint in Graves' disease.

Authors:  Xiaoming Yin; Ravi Sachidanandam; Syed Morshed; Rauf Latif; Ruijin Shi; Terry F Davies
Journal:  J Clin Endocrinol Metab       Date:  2014-06-27       Impact factor: 5.958

7.  Synthesis and biological evaluation of [(18)F]tetrafluoroborate: a PET imaging agent for thyroid disease and reporter gene imaging of the sodium/iodide symporter.

Authors:  Maite Jauregui-Osoro; Kavitha Sunassee; Amanda J Weeks; David J Berry; Rowena L Paul; Marcel Cleij; Jasvinder Paul Banga; Michael J O'Doherty; Paul K Marsden; Susan E M Clarke; James R Ballinger; Istvan Szanda; Sheue-Yann Cheng; Philip J Blower
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-06-25       Impact factor: 9.236

8.  Expression of the Na+/I- symporter (NIS) is markedly decreased or absent in gastric cancer and intestinal metaplastic mucosa of Barrett esophagus.

Authors:  Aron Altorjay; Orsolya Dohán; Anna Szilágyi; Monika Paroder; Irene L Wapnir; Nancy Carrasco
Journal:  BMC Cancer       Date:  2007-01-10       Impact factor: 4.430

9.  Imaging characteristics, tissue distribution, and spread of a novel oncolytic vaccinia virus carrying the human sodium iodide symporter.

Authors:  Dana Haddad; Chun-Hao Chen; Sean Carlin; Gerd Silberhumer; Nanhai G Chen; Qian Zhang; Valerie Longo; Susanne G Carpenter; Arjun Mittra; Joshua Carson; Joyce Au; Mithat Gonen; Pat B Zanzonico; Aladar A Szalay; Yuman Fong
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

10.  Early Quantification of Salivary Gland Function after Radioiodine Therapy.

Authors:  Karan Singh Tanwar; Nivedita Rana; Bhagwant Rai Mittal; Anish Bhattacharya
Journal:  Indian J Nucl Med       Date:  2021-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.